Granules India surges on getting marketing approval for Acetaminophen Extended-Release Tablets

30 Aug 2021 Evaluate

Granules India is currently trading at Rs. 336.00, up by 5.15 points or 1.56% from its previous closing of Rs. 330.85 on the BSE.

The scrip opened at Rs. 332.40 and has touched a high and low of Rs. 337.50 and Rs. 330.15 respectively. So far 69198 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 438.00 on 01-Dec-2020 and a 52 week low of Rs. 282.35 on 31-Aug-2020.

Last one week high and low of the scrip stood at Rs. 338.75 and Rs. 315.70 respectively. The current market cap of the company is Rs. 8297.11 crore.

The promoters holding in the company stood at 42.04%, while Institutions and Non-Institutions held 21.21% and 36.76% respectively.

Granules India has received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of Arthritis Pain. The product manufactured by Granules is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets. The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad. Granules now have a total of 2 ANDS approvals from Health Canada.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

598.25 -0.10 (-0.02%)
31-Dec-2025 09:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.90
Dr. Reddys Lab 1262.60
Cipla 1495.00
Zydus Lifesciences 908.95
Lupin 2083.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×